Clinical Trial: Iloprost in Acute Respiratory Distress Syndrome

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

Official Title: Therapeutic Iloprost for the Treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial)

Brief Summary: The patients will be randomized into one of two groups. Both groups will receive standard care as is state of the art. The intervention group will receive Iloprost nebulized as inhalative therapy.

Detailed Summary:
Sponsor: University Hospital Tuebingen

Current Primary Outcome: overall survival [ Time Frame: 90 days ]

all cause mortality in 90-day follow up-period


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospital Tuebingen

Dates:
Date Received: April 6, 2017
Date Started: June 2018
Date Completion: January 2021
Last Updated: April 25, 2017
Last Verified: April 2017